Promotion of Research and Innovation in Pharma (PRIP) scheme (PIB)
- 27 Sep 2023
What is the News ?
The Indian Government, led by the Minister of Chemicals and Fertilizers and the Minister of Health & Family Welfare, has just introduced a new program called PRIP. This program aims to support and encourage research and innovation in the Pharma and MedTech sectors.
Facts About:
- The PRIP scheme has a clear goal: to shift the Indian pharmaceutical sector from being focused on costs to being driven by innovation.
This means we want to encourage more research and new ideas in the country.
- Aim: We want to create stronger connections between industries and educational institutions to do research in important areas.
This will help us build a culture of high-quality research and support our scientists.
- By doing this, we hope India will be more competitive on the global stage, and it will also create better job opportunities.
- How Long It Will Last: This program will run for five years, from 2023-24 to 2027-28.
- The Scheme Has Two Parts:
Part A: We will invest Rs 700 Crores to set up 7 Centers of Excellence (CoEs) at the National Institutes of Pharmaceutical Education and Research (NIPERs). These will focus on specific areas of research.
Part B: We will support research in six important areas like new medicines, complex generics, medical devices, stem cell therapy, rare disease drugs, and fighting against drug resistance. This will also include helping industries, small businesses, startups, and academic research.
- Total Budget: The program has a total budget of Rs. 4250 Crores.
- This scheme is all about making pharmaceutical research in India stronger and more innovative.
- It will support researchers and industries working on important health-related projects.